TCT 2024 | Distal Radial vs Transradial Approach in STEMI Patients

The transradial approach (TRA) has been recommended for patients with ST-elevation myocardial infarction (STEMI) for reduced bleeding complications and mortality. However, evidence in support of the use of distal radial access (DRA) in these patients is limited. This study aimed at showing DRA puncture success rate would be no inferior than that of TRA.

Primary endpoint was puncture success rate. Secondary endpoints included coronary angiography and angioplasty success rates, bleeding complications, puncture, procedural, hemostasis and fluoroscopy time, contrast volume, and major adverse cardiovascular events (MACE), including all-cause death, myocardial infarction, and revascularization.

A total of 354 patients were randomized: 174 were assigned to DRA and 175 to TRA. Puncture success rate resulted 94.3% for DRA patients vs. 96.1% for TRA. 

Read also: STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes.

Access site bleeding was more frequent among TRA patients vs. DRA, though not statistically significant. No significant differences were found when looking at secondary endpoints.

Conclusión  

In this multicenter study of STEMI patients, DRA vs TRA puncture success rate resulted inconclusive in both intention-to-treat and per-protocol analyses. However, DRA was shown non-inferior based on treatment. Large-scale studies are needed to confirm these findings.

Original Title: Comparison of Puncture Success Rate between Distal Radial Access and Transradial Access in Patients with ST-elevation Myocardial Infarction.

Reference: Jun-Won LEE, MD, PhD et al TCT 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...